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Abstract
Recently we identified multiple suramin-sensitivity genes with a genome wide screen in Try-
panosoma brucei that includes the invariant surface glycoprotein ISG75, the adaptin-1 (AP-
1) complex and two deubiquitylating enzymes (DUBs) orthologous to ScUbp15/HsHAUSP1
and pVHL-interacting DUB1 (type I), designated TbUsp7 and TbVdu1, respectively. Here
we have examined the roles of these genes in trafficking of ISG75, which appears key to
suramin uptake. We found that, while AP-1 does not influence ISG75 abundance, knock-
down of TbUsp7 or TbVdu1 leads to reduced ISG75 abundance. Silencing TbVdu1 also
reduced ISG65 abundance. TbVdu1 is a component of an evolutionarily conserved ubiqui-
tylation switch and responsible for rapid receptor modulation, suggesting similar regulation
of ISGs in T. brucei. Unexpectedly, TbUsp7 knockdown also blocked endocytosis. To inte-
grate these observations we analysed the impact of TbUsp7 and TbVdu1 knockdown on
the global proteome using SILAC. For TbVdu1, ISG65 and ISG75 are the only significantly
modulated proteins, but for TbUsp7 a cohort of integral membrane proteins, including the
acid phosphatase MBAP1, that is required for endocytosis, and additional ISG-related pro-
teins are down-regulated. Furthermore, we find increased expression of the ESAG6/7 trans-
ferrin receptor and ESAG5, likely resulting from decreased endocytic activity. Therefore,
multiple ubiquitylation pathways, with a complex interplay with trafficking pathways, control
surface proteome expression in trypanosomes.
Author Summary
The mechanisms by which pathogens interact with their environment are of major impor-
tance, both for fulfilling the basic needs of the parasite and understanding immune eva-
sion. For African trypanosomes, the surface is dominated by the variant surface
glycoprotein (VSG), but recent data has demonstrated an important role for ubiquitylation
in mediating turnover of invariant surface glycoproteins (ISGs) and maintaining ISG copy
PLOS Pathogens | DOI:10.1371/journal.ppat.1005236 October 22, 2015 1 / 26
a11111
OPEN ACCESS
Citation: Zoltner M, Leung KF, Alsford S, Horn D,
Field MC (2015) Modulation of the Surface Proteome
through Multiple Ubiquitylation Pathways in African
Trypanosomes. PLoS Pathog 11(10): e1005236.
doi:10.1371/journal.ppat.1005236
Editor: Kent L. Hill, University of California, Los
Angeles, UNITED STATES
Received: May 24, 2015
Accepted: September 28, 2015
Published: October 22, 2015
Copyright: © 2015 Zoltner et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was funded by the Medical
Research Council (GB) (www.mrc.ac.uk) by grant
number MR/K008749/1 to MCF and DH. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
number independent of VSG. Further, ISG expression is required for suramin-sensitivity.
Here we describe mechanisms mediating ISG turnover, uncovered using a screen for genes
involved in sensitivity to suramin. These involve multiple aspects of the ubiquitylation
machinery, and connect ISG turnover with additional surface proteins. Our data provide a
first insight into the complexity of regulation of the ISG family, identifying further aspects
to the control of a drug-sensitivity pathway in trypanosomes, and offering insights into
metabolism of the parasite surface proteome.
Introduction
Trypanosoma brucei is the causative agent of human African trypanosomiasis (HAT) and
nagana, and severely impacts both human health and economic prosperity in sub-Saharan
Africa. HAT is subdivided into two forms; acute caused by the T. b. gambiense subspecies and
chronic caused by T. b. rhodesiense. Currently, five drugs are available to treat HAT and, while
deployment depends on disease stage and subspecies, adverse toxicity, complex administration
regimes and emerging resistance all contribute to the need for new therapies and improved
understanding of the mechanisms by which existing drugs act [1]. Recent appreciation of T.
evansi and T. equiperdum as very closely related to T. brucei extends the impact of the African
trypanosomes to much of Asia and Latin America [2].
Bloodstream-form trypanosomes exhibit a highly efficient endocytic system that enables
rapid recycling of surface proteins, antibody clearance and nutrient uptake. This is reflected by
the presence of the flagellar pocket, a defined membrane region at the flagellar base, dedicated
to incoming and outgoing membrane traffic [3]. This organelle facilitates rapid uptake and
recycling of variant surface glycoproteins (VSGs), dimeric, glycosylphosphatidylinositol (GPI)
anchored glycoproteins that dominate the cell-surface at this life cycle stage. The dense VSG
surface coat, that has the ability to undergo antigenic variation by switching between immuno-
logically distinct VSG variants, is recognized as the primary defence against both, innate and
acquired immune response [4].
Intercalated with the VSG-coat are trans-membrane-domain (TMD) proteins. Invariant
surface glycoprotein (ISG) families are amongst the most abundant TMD-proteins of blood-
stream form T. brucei [5,6], with ISG65 and ISG75 estimated at 70,000 and 50,000 copies per
cell, respectively [7]. Significantly, both these type I TMD proteins are modified by ubiquityla-
tion, with internalisation and degradation depending on ubiquitylation at specific cytoplasmic
residues [7,8]. In higher eukaryotes, ubiquitylated proteins destined for the lysosome are regu-
lated by the endosomal sorting complex required for transport (ESCRT) machinery, where ubi-
quitylated proteins are recognised and sorted into multivesicular bodies (MVBs) [9]; similar
pathways probably operate in trypanosomes [10].
Recent studies linked ISG75 to the action of suramin [11], the oldest trypanosome drug
remaining in the pharmacopeia, but which is only useful in the clinic against early stage T. b.
rhodesiense [12]. Using genome wide RNAi-target sequencing we identified a cohort of genes
involved in sensitising trypanosomes to suramin [11]. This implicated, along with ISG75, mul-
tiple proteins with roles and/or locations at the endocytic pathway, including a major facilitator
superfamily transporter (MFST) [13], two deubiquitylating enzymes (DUBs) orthologous to
human Usp7 and Vdu1, the AP-1 adaptin complex [14], Golgi/lysosomal protein-1 (GLP-1)
[15], the trypanosome ortholog of Vps5 [16], cathepsin-L (CatL) [17,18] and the essential lyso-
somal protein p67 [19,20]. Specific knockdowns of several of the above, including the two
DUBs, significantly increased suramin resistance ([11] and S1 Fig). The absence of many
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central endocytic genes, e.g. clathrin, Rab5 and Rab7, from the suramin sensitivity gene cohort
likely arises from the severe lethality that knockdown of these genes elicits.
AP-1 is involved in bi-directional clathrin-dependent transport between the trans-Golgi
network (TGN) and endosomes in higher eukaryotes [21], and while its role in T. brucei is less
clear, AP-1 does participate in trafficking of lysosomal protein p67 in bloodstream form try-
panosomes, potentially connecting these suramin-sensitivity genes [14,22]. Further, the
absence of the AP-2 complex in T. brucei suggests that AP-1 likely assumes a more prominent
endocytic role in African trypanosomes [23]. Significantly, no cargo-specific DUBs are known
in trypanosomatids, but it is possible that ISG75 and the DUBs identified as suramin-sensitivity
determinants are in some manner connected. Suramin most likely gains access to the cyto-
plasm via the MFST family of transporters, to interfere with additional cellular functions,
including glycolysis [24,25].
Our current model is that suramin binds to ISG75 and is delivered via endocytosis to the
lysosome, where CatL releases suramin from its binding partner [26]. However, definitive evi-
dence for a direct interaction with ISG75 and a role for ISG75 as the suramin receptor remains
to be obtained. Further, we have not integrated the role of the AP-1 complex into our model.
We previously demonstrated that TbUsp7 knockdown specifically decreased ISG75, but not
ISG65, expression levels. Given the similarities in architecture, trafficking, stage-specific
expression and evolutionary histories, these findings suggest a complex mechanism underpin-
ning ISG expression, and thus suramin sensitivity.
To define the pathways affecting these processes, we examined the roles of TbUsp7,
TbVdu1 and TbAP-1 on ISG trafficking, combining knockdown, imaging, analysis of ISG
turnover, as well as global proteome analysis. We find a complex interaction between ISGs and
deubiquitylation pathways, as well as connections to additional surface proteins, indicating
connectivity between ISG trafficking, endocytosis and nutrient acquisition. These data, in con-
junction with our earlier findings [11], also demonstrate that sensitivity of bloodstream-form
trypanosomes to suramin is dependent on their uniquely active endocytic apparatus, and fur-
ther confirms that exploitation of this pathway has significant potential for the development of
novel therapeutics.
Results
AP-1 is not required for either localisation or stability of suramin-
sensitivity gene products
All four subunits of the trafficking adaptor, AP-1, were identified in our screen for suramin-
sensitivity. Given the known roles for this complex in post-Golgi trafficking in higher eukary-
otes, we first asked if trafficking and stability of proteins located at the surface or within the
endosomal system identified in the suramin screen are regulated by AP-1 [11]. Since knock-
down of any AP-1 subunit destabilises the remaining proteins in the complex [14], steady state
levels of GLP-1, CatL and MFST were assessed following AP-1γ knockdown [14]. RNAi
strongly decreased AP-1γ protein levels (~90%), but no significant changes in steady state lev-
els of GLP-1 were found and only a small increase in CatL level was seen (Fig 1A). As we were
unable to obtain reliable data for MFST12myc by Western blotting, we used immunofluores-
cence (IF) to monitor MFST localisation and copy number. The locations of GLP-1, CatL and
MFST were unaffected by AP-1 knockdown, with no significant differences in signal intensity
between uninduced and induced cells, suggesting that neither trafficking nor expression levels
of these proteins depends significantly on AP-1. AP-1 knockdown also had no obvious effect
on ISG65 and ISG75 localisation (Fig 1C), steady state levels or turnover (Fig 1A and 1D).
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Fig 1. The effect of AP-1γ RNAi onmarkers of the endocytic pathway. All experiments were performed in uninduced (-) or induced (+) cells for 18 hours.
(A) Western blot and (B) immunofluorescence for GLP-1, CatL, MFST12myc, (C) ISG65 and ISG75. In B and C scale bar = 2.5 μm, protein antigens are shown
in red, DNA visualised with DAPI is in blue. (D) AP-1γ RNAi cells were subjected to RNAi knockdown followed by cycloheximide treatment. Cells were
harvested at various time points and endogenous ISG65 and ISG75 levels were monitored by western immunoblotting. β-tubulin was used as a loading
control. Lower panel shows quantification, with open symbols induced (+) and closed symbols uninduced (-) and representing the mean of three independent
experiments, with the standard error indicated.
doi:10.1371/journal.ppat.1005236.g001
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We conclude that ISG65 and ISG75 are either targeted by an AP-1-independent mechanism
or that a redundant pathway assumes the role of AP-1 in its absence. It is likely that the absence
of a major effect on ISG reflects the specific roles of AP-1. Significantly, another suramin sensi-
tivity determinant, the lysosomal membrane protein p67, depends on AP-1 for its lysosomal
delivery. Evidence suggests that trafficking of p67 is via a distinct route from ISGs that does
not involve transport through the flagellar pocket. Moreover, p67 trafficking is reliant on classi-
cal dileucine motifs within the cytoplasmic domain. Hence, the identification of the AP-1 com-
plex as a suramin sensitivity determinant probably reflects a role in the trafficking of p67 or
other lysosomal proteins required to maintain the lysosomal environment necessary for sura-
min action [11, 14, 20, 22, 27].
Suramin-sensitivity DUBs are evolutionarily conserved
The suramin-sensitivity screen identified two deubiquitylating enzymes, encoded by
Tb927.9.14470 and Tb927.11.12240. In silico analysis indicated that both are evolutionarily
conserved across eukaryotes, with the human orthologs being USP7 and VDU1, respectively,
and therefore we designated these gene products as TbUsp7 and TbVdu1. Significantly, USP7
is involved in multiple pathways including cell cycle control, epigenetics and the immune
response, and is the target of anti-oncogenesis drug screening efforts [28]. Conversely, VDU1
is predicted as membrane-associated and part of a complex ubiquitylation switch controlling
expression of the HIF-1α transcription factor [29]. VDU1 exists in a complex with an Rbx/cul-
lin/elongin E3 ubiquitin ligase that provides a rapid mechanism for downregulation of receptor
tyrosine kinases upon ligand binding, and orthologs of all components of this E3 ubiquitin
ligase are present in the T. brucei genome, suggesting that trypanosomes possess an analogous
complex.
TbUsp7 and TbVdu1 have roles in ISG trafficking
Cells harbouring stem-loop RNAi constructs specific for either TbUsp7 or TbVdu1 were
induced with tetracycline and their mRNA abundance assessed by qRT-PCR; both were
silenced by over 60% (Fig 2A). We previously observed growth defects for TbUsp7 under these
conditions [11], but in contrast, knockdown of TbVdu1, a probable membrane-associated pro-
tein confined to the flagellar pocket region, did not impact proliferation (S1 Fig). Furthermore,
while knockdown of TbVdu1 did not induce morphological defects at the light microscopy
level, knockdown of TbUsp7 led to enlargement of the flagellar pocket, the ‘BigEye’ phenotype
originally observed for knockdown of clathrin, and consistent with the proliferative defect
resulting from TbUsp7 RNAi (Fig 2B and [30]). Quantification revealed that ~20% of cells in
TbUsp7 knockdown cultures possess the BigEye morphology, constituting a 40-fold increase in
BigEye frequency, compared with ~5-fold increase for TbVdu1 knockdown (Fig 2C).
As enlargement of the flagellar pocket suggests an endocytic block, we monitored endocyto-
sis with fluorescent-ConA in TbUsp7 and TbVdu1 knockdown cells. ConA rapidly enters into
early endosomes and is subsequently delivered to the lysosome in trypanosomes, a process
unaffected by TbVdu1 knockdown (S2 Fig). In contrast, TbUsp7 knockdown blocked ConA
uptake in BigEye cells (Figs 2D and S2), with ConA remaining at the flagellar pocket over the
course of the assay. TbUsp7 knockdown cells without the BigEye phenotype displayed ConA
trafficking similar to uninduced cells, confirming that the BigEye morphology was indeed asso-
ciated with blocked endocytosis. While the kinetics of appearance of the BigEye morphology
was significantly slower than following clathrin knockdown, it was similar to knockdown of
several other proteins acting within the endosomal apparatus, for example Rab5 [31] and
TbCAP116 [32], suggesting that modification of a critical component of the endosomal
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apparatus is impacted by TbUsp7 knockdown or that the protein has some direct role in endo-
cytosis. We therefore asked whether TbUsp7 knockdown impacts clathrin itself, as Rab5
knockdown leads to a BigEye phenotype via decreased expression of clathrin [31]. However,
steady state levels of clathrin were unaffected (S3 Fig), suggesting another molecular target.
Knockdown of clathrin leads to increased ISG75 ubiquitylation
ISG65 and ISG75 are both ubiquitylated in vivo, but the location where this modification
occurs is unknown. To determine if ubiquitylation required entry to the cell interior or could
occur at the cell surface, we performed RNAi knockdown of clathrin and monitored both
steady state expression and the ubiquitylation status of ISG65 and ISG75. Clathrin knockdown
results in decreased intracellular ISG65 with a concomitant increase in steady state levels of
ISG65 (Fig 3A), consistent with a block in endocytosis and degradation [7]. By contrast, cla-
thrin knockdown had no effect on steady state levels of ISG75 (Fig 3A). Furthermore, while we
did not observe a significant difference in the ubiquitylation profile of ISG65 in clathrin knock-
down relative to uninduced cells, ISG75 consistently showed increased ubiquitylation (Fig 3B).
As endocytosis has been blocked, this indicates that ISG75 is likely ubiquitylated at the cell sur-
face and prior to internalisation, but there is no similar evidence for ISG65. Together, these
Fig 2. TbUsp7 but not TbVdu1 knockdown perturbs endocytosis. (A) Knockdown of TbUsp7 and TbVdu1 in the presence (+, open bar) or absence
(-, closed bar) of RNAi induction as measured by qRT-PCR. Results were normalised to β-tubulin and error bars denote the standard error of the mean
(n = 3). (B) Phase contrast images showing the presence or absence of the BigEye phenotype under TbUsp7 and TbVdu1 knockdown. The enlarged flagellar
pocket is indicated by a black arrowhead. Scale bar = 2.5 μm. (C) One hundred cells were analysed from uninduced or induced cultures of TbVdu1 (open
bar) or TbUsp7 (closed bar) and scored for the appearance of an enlarged flagellar pocket, manifest as a phase-light vacuole at the posterior end of the cell.
Results represent an average of four independent experiments with error bars denoting the standard error. (D) ConA uptake in the presence and absence of
TbUsp7 knockdown. Following induction of RNAi, cells were incubated with FITC-conjugated ConA (green). Note that only an example of a cell with an
enlarged flagellar pocket is presented for TbUsp7. Induced cells that do not display this morphology have normal ConA uptake. Scale bar = 2.0 μm. All cells
were co-stained with DAPI (blue) to visualise nuclear and kinetoplast DNA.
doi:10.1371/journal.ppat.1005236.g002
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Fig 3. Clathrin knockdown increases ubiquitylation of ISG75. (A) Levels of clathrin heavy chain (CHC),
ISG65 and ISG75 were monitored following RNAi knockdown of clathrin for 12 hours by western
immunoblotting. β-tubulin was used as loading control and relative protein abundance was quantified by
densitometry. (B) Endogenous ISG65 and ISG75 were immunoprecipitated using specific antibodies
followed by western immunoblotting with anti-ubiquitin antibody. A western immunoblot from the same
samples prior to immunoprecipation and probed with anti-β-tubulin was used as a loading control.
doi:10.1371/journal.ppat.1005236.g003
Modulating Surface Protein Expression Level in Trypanosomes
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data suggest that while ISG65 and ISG75 are both ubiquitylated, the modification likely occurs
at different sub-cellular locations and by distinct mechanisms.
ISG65 and ISG75 expression levels depend on TbUsp7 and TbVdu1
We next assessed expression levels of ISG65 and ISG75 following knockdown of the two
DUBs. TbUsp7 knockdown resulted in strongly decreased ISG75 expression (to ~20%) but not
ISG65, as previously shown [11]. Significantly, TbVdu1 knockdown led to decreases in both
ISG75 (to ~60%) and ISG65 (to ~35%) (Fig 4A).
These observations were corroborated by immunofluorescence microscopy, where intracel-
lular pools of ISG75, but not ISG65, were significantly diminished by TbUsp7 knockdown,
while both ISG65 and ISG75 were reduced on TbVdu1 knockdown (Fig 4B). Where a residual
intracellular signal was observed in TbVdu1 knockdown cells, ISG65 and ISG75 remained
localised to posterior endomembrane compartments, and hence were not significantly misloca-
lised. However, in cells exhibiting the BigEye phenotype following TbUsp7 knockdown, ISG65
and ISG75 staining accumulated at the enlarged flagellar pocket, presumably retained due to
blocked endocytosis (Fig 4B). Overall, these data suggest that while ISG65 and ISG75 are not
mistargeted, decreased expression level represents the primary impact of TbUsp7 or TbVdu1
knockdown.
TbUsp7 and TbVdu1 control ISG turnover
We next examined degradation rates for ISG65 and ISG75 in DUB knockdowns by blocking
protein synthesis with cycloheximide and measuring protein abundance by Western blotting.
While ISG75 was significantly destabilised, ISG65 degradation was unaffected by TbUsp7
knockdown (Fig 5A). In contrast, both ISG65 and ISG75 were turned over more rapidly in
TbVdu1 knockdown cells (Fig 5B). All of these observations indicate that the major mecha-
nism underpinning lower ISG65 and ISG75 expression levels is decreased stability/increased
turnover in DUB knockdown cells, consistent with an inhibitory effect of DUBs on ISG ubiqui-
tylation levels.
Effect of DUB knockdown on ISG transcript and de novo synthesis
To determine if the impact of DUB knockdown on ISG expression was due to changes in syn-
thesis or turnover, we initially quantified the respective mRNAs by qRT-PCR. While no signifi-
cant differences were observed in transcript levels for either ISG when TbVdu1 was knocked
down, we observed almost twice as much ISG75 mRNA in the presence of TbUsp7 knockdown
compared with uninduced cells (Fig 6A). This suggests the presence of a feedback mechanism
able to upregulate ISG75 transcript levels in order to maintain copy number upon protein
destabilisation. The lack of evidence for decreased ISG mRNA levels in either DUB knock-
down, indicates that reduced transcription can be excluded as an explanation for the observed
decrease in ISG protein level.
To examine if decreased translation could account for lower ISG expression level following
DUB knockdown, cells were pulse-labelled for one hour with 35S-methionine followed by
immunoprecipitation of ISG65 and ISG75. We observed a small effect on 35S-methionine
incorporation into ISG65 following TbVdu1 depletion, but this was substantially less than the
observed destabilisation. We saw more pronounced decreased 35S-methionine incorporation
into ISG75 following TbUsp7 (~60% decrease) or TbVdu1 (~30% decrease) knockdown (Fig
6B). While we cannot exclude that ISG75 biosynthesis is affected by DUB knockdown, given
that the cells were pulse-labelled for 60 minutes and ISG75 is turned over rapidly following
DUB knockdown (T1/2 1.5 and 2.0 hours following TbUsp7 and TbVdu1 knockdown,
Modulating Surface Protein Expression Level in Trypanosomes
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Fig 4. Knockdown of TbUsp7 and TbVdu1 differentially reduces steady state ISG65 and ISG75 levels. (A) Steady state levels of endogenous ISG65
and ISG75 in the presence (+) or absence (-) of TbUsp7 and TbVdu1 knockdown were assessed by western immunoblotting. β-tubulin was used as a loading
control. Bar graphs represent the mean of three independent experiments normalised to uninduced cells at 100% (dotted line), with the standard error
indicated. (B) The location and levels of ISG65 and ISG75 were assessed by immunofluorescence in the presence or absence of TbUsp7 or TbVdu1
knockdowns (+ or -, respectively). Cells with enlarged flagellar pockets (“BigEye”) in the presence of TbUsp7 RNAi are also shown. Cells were stained with
DAPI (blue) to visualise nuclear and kinetoplast DNA, while ISG65 and ISG75, visualised with specific polyclonal antibodies, are shown in red. Scale
bar = 2.5 μm.
doi:10.1371/journal.ppat.1005236.g004
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Fig 5. ISG65 and ISG75 turnover under TbUsp7 and TbVdu1 knockdown. (A) TbUsp7 and (B) TbVdu1 RNAi knockdown was followed by cycloheximide
treatment. Cells were harvested at various time points and endogenous ISG65 and ISG75 levels were monitored by western immunoblotting. β-tubulin was
used as a loading control. Closed symbols indicate uninduced (-) and open symbols induced (+) cultures. Graphs represent the mean of three independent
experiments, with the standard error indicated.
doi:10.1371/journal.ppat.1005236.g005
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Fig 6. Assessment of ISG65 and ISG75 transcription and biosynthesis under TbUsp7 and TbVdu1 knockdown. (A) ISG65 and ISG75 transcript levels
were determined in the presence (+, open bars) or absence (-, closed bars) of TbUsp7 and TbVdu1 knockdown by qRT-PCR normalised to β-tubulin. Error
bars denote standard error of the mean. (B) Biosynthesis of ISG65 and ISG75 were monitored by immunoprecipitation using specific polyclonal antibodies, in
the presence (+) or absence (-) of TbUsp7 and TbVdu1 knockdown. Bar graphs represent the mean of three independent knockdown experiments (open
bars) normalised to uninduced (closed bars) cells, with the standard error indicated. Statistical analysis: Student’s t-test; *p<0.05, **p<0.01.
doi:10.1371/journal.ppat.1005236.g006
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respectively, Fig 5A and 5B), accelerated turnover likely accounts for the majority of the
decrease in ISG75 labelling, as a substantial portion of the labelled ISG75 would have been
degraded even during the 35S-pulse period. Taken together, these data indicate that the major-
ity of observed changes in ISG65 and ISG75 expression following DUB depletion likely arise
from accelerated turnover rather than biosynthesis, suggesting that the DUBs influence ISG
modification directly.
The cytoplasmic domain of ISG75 is sufficient for TbUsp7-mediated
destabilisation
As knockdown of TbUsp7 and TbVdu1 has such a profound effect on ISG75 expression, we
were unable to monitor the ubiquitylation status of ISG75 under these conditions, as even in
wild type cells ubiquitylated adducts of ISG75 are a very minor fraction, and attempts to detect
such adducts in TbUsp7 knockdowns were unsuccessful. As an alternative approach, we rea-
soned that if TbUsp7 was acting directly on ISG75, then a reporter construct that bore the ubi-
quityation sites, but lacked the ISG75 ectopic domain would behave in a similar manner to
ISG75 in TbUsp7 knockdown cells.
TbUsp7 RNAi cells were transfected to overexpress BiPN-ISG75L, a reporter containing the
BiP ATPase N-terminal domain (BiPN) fused to an HA-tag and followed by the trans-
membrane and cytoplasmic domain of ISG75 [8]. As before, we observed an increased destabi-
lisation of ISG75 both at steady state (at time 0 h) and over time following TbUsp7 knockdown,
and also increased turnover of BiPN-ISG75L relative to uninduced cells (Fig 7). These data
indicate that the cytoplasmic domain of ISG75 is sufficient for TbUsp7-mediated stabilisation,
Fig 7. DUB-knockdownmediated expression level changes depend on cytoplasmic domain
sequences. BiPN-ISG75L is a chimeric reporter construct containing the BiP ATPase N-terminal domain
fused to an HA epitope tag followed by the trans-membrane and cytoplasmic domain of ISG75. Cells were
grown in the presence (+) or absence (-) of TbUsp7 RNAi for 48 hours followed by treatment with
cycloheximide for the indicated times. The levels of HA-BiPN-ISG75L and endogenous ISG75 were
assessed at different time points by western immunoblotting with anti-HA or anti-ISG75 antibodies. β-tubulin
was used as a loading control.
doi:10.1371/journal.ppat.1005236.g007
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and suggests that modulation of ubiquitylation likely accounts for altered ISG75 expression
levels.
TbVdu1 and TbUsp7 differentially interact with the trypanosome
proteome
To extend our understanding of interactions between TbUbp7 and TbVdu1 and the parasite
surface, we analysed the effect of DUB knockdown on the whole cell proteome using stable iso-
tope-labeling by amino acids in culture (SILAC, see methods). As maximal knockdown for
both DUBs was achieved by 48 hours, we examined cells at 26 and 48 hours after induction for
TbUsp7, and at 48 hours for TbVdu1 knockdown. We were able to quantify 1769, 1823 and
1879 distinct proteins from these analyses respectively, representing approximately 25% of the
total cellular proteome. As the vast majority of proteins were unaltered, this indicates that the
detected changes are specific and not the result of general toxicity arising from the knockdown.
The impact of TbUsp7 and TbVdu1 on ISG65 and ISG75 determined by SILAC (see
Table 1, Fig 8) was in perfect agreement with semi-quantitative Western blotting (see above).
TbUsp7 knockdown reduced ISG75 abundance to ~40% after 48 hours, whilst total ISG65 lev-
els were unchanged. TbVdu1 knockdown decreased ISG75 and ISG65 to ~55% and ~65% after
48 hours, respectively. ISG75 paralogs were equally affected by the DUB knockdowns, and sim-
ilarly the ISG65 paralogs were also decreased uniformly. Furthermore, SILAC analyses revealed
an impact of TbVdu1 knockdown on additional proteins, including a distant ISG paralog,
Tb927.5.630, that was also decreased.
Perturbation of the proteome by TbUsp7 knockdown was more extensive, necessitating a
kinetic analysis. We considered as significant only those proteins where changes were seen at
both sampled time points and also where the magnitude of that change increased between the
26 and 48 hour datasets. Significantly, the membrane-bound histidine acidic phosphatase
MBAP1 decreased to 29% at 48 hours. This well-characterised trans-membrane protein pos-
sesses a topology similar to ISGs and is essential for both endocytosis and exocytosis [33]. Two
predicted bitopic membrane proteins and a multi-spanning trans-membrane protein, all with
unknown function, were decreased to a similar degree. Furthermore, the vesicle associated
SNARE protein VAMP7B, which localises to endosomes (Divya Venkatesh and MCF, in prep-
aration) and a TPR-repeat containing protein were also decreased. Finally, a small cohort of
bloodstream stage-specific GPI-anchor containing proteins was significantly upregulated fol-
lowing TbUsp7 knockdown. The majority of these are VSG expression site-associated genes
(ESAGs). ESAG6 and ESAG7, the transferrin receptor [34,35] increased two-fold (Table 1, Fig
8). ESAG5 and to a much lesser extent ESAG2 also increased; these have recently been shown
to be surface or endomembrane system proteins [6]. ESAG5 contains BPI (bactericidal/perme-
ability-increasing protein)/LBP (lipopolysaccharide-binding protein)/PLUNC (palate, lung
and nasal epithelium clone)-like domains [36], and based on this architecture is proposed to
bind lipid or lipopolysaccharide and have a signalling function [37].
Remarkably specific alterations to the trypanosome proteome result from DUB knockdown.
These data explain the endocytosis defect resulting from TbUsp7 RNAi, as downregulation of
MBAP1 is known to lead to an enlarged flagellar pocket. Given the topology of MBAP1 and
the presence of several lysine residues within the short cytoplasmic region, we speculate that
MBAP1 is likely ubiquitylated, and hence TbUsp7 may participate in controlling its expression.
Increases to expression of ESAG6/7 probably arise from the endocytosis defect, as trypano-
somes precisely regulate expression of the transferrin receptor to maintain iron homeostasis
[38].
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Table 1. Percentage abundance of selected protein groups upon TbUsp7 and TbVdu1 RNAi derived from normalised SILAC ratios. Values repre-
sent average percentage protein abundance relative to uninduced cells ± standard deviation. TbUsp7 and TbVdu1 RNAi samples were analysed at indicated
time points in experimental duplicate and triplicate, respectively. Asterisks mark proteins not quantified in all replicates. Polypeptide features predicted using
TMHMM2 for trans-membrane domains [39], signalP for N-terminal ER-targeting signal [40], PredGPI for GPI-anchor addition C-terminal signal sequence
[41] and TPRpred for tetratrico peptide repeats [42]. Predictions are given as Yes, No responses or sequence positions (inclusive signal sequence) using
default parameters. In most cases the topology of the protein is experimentally known or predictable based on close homology of experimentally derived infor-
mation. All protein hits shown have been inspected for their genomic context and integrity. Protein groups consist of indistinguishable paralogs, sharing identi-
cal quantified peptides. For the complete quantification data see S1 Table. NA; not applicable, ND; not detected.
Annotation Protein group Protein abundance upon RNAi
(percent relative to non-induced)
Predicted features Predicted
Trans-
membrane
domain
Predicted N-
terminal
signal
Number of
lysines in
cytoplasmic
domain
Predicted
GPI-anchor
Sequence
length
(inclusive
signal seq.)TbUsp7 26h TbUsp7 48h TbVdu1 48h
USP7 Tb927.9.14470 28 * 13 * 101 (+/- 3) USP7_C2
superfamily
No No NA NA 1161
VDU1 Tb927.11.12240 ND 105 * ND Peptidase_C19
superfamily
No No NA NA 790
ISG75 Tb927.5.390 43 (+/- 4) 40 (+/-34) 52 (+/- 5) ISG65-75
superfamily
468–490 Yes 5 NA 522
Tb927.5.400 468–490 4 522
Tb927.5.350 468–490 4 522
Tb927.5.360 42 (+/- 3) 39 (+/-26) 53 (+/- 4) ISG65-75
superfamily
469–491 Yes 5 NA 523
Tb927.5.370 ND ND 64 (+/-23) * ISG65-75
superfamily
469–491 Yes 5 NA 523
ISG65 Tb927.2.3280 96 (+/- 2) 117(+/-5) 69 (+/- 8) ISG65-75
superfamily
386–408 Yes 4 NA 436
Tb927.2.3290 388–410 4 436
Tb927.2.3300 388–410 4 436
Tb927.2.3310 388–410 3 436
Tb927.2.3320 97 (+/- 2) 109(+/-41) 45 (+/- 2) ISG65-75
superfamily
387–409 Yes 3 NA 437
Tb927.2.3270 90 (+/- 2) 105(+/-22) 62 (+/- 8) ISG65-75
superfamily
388–410 Yes 4 NA 436
Tb11.v5.0231 469–491 5 523
Tb11.v5.0731 388–410 2 430
ISG-related Tb927.5.630 75 (+/- 3) 79 (+/-16) 76 (+/- 11) ISG65-75
superfamily
349–372 Yes 4 NA 401
ISG64 Tb927.5.1390* 92 (+/- 3) 98 (+/- 2) 87 (+/- 19) ISG65-75
superfamily
376–398 Yes 4 NA 434
Tb927.5.1410 377–399 4 435
Tb927.5.1430 97 (+/- 9) 107(+/- 5) 94 (+/- 20) ISG65-75
superfamily
376–398 Yes 4 NA 434
MBAP1 Tb927.11.13130 50(+/- 1) 29 (+/-2) 101 (+/- 11) acidic phosphatase
[33]
459–481 Yes 2 No 524
putative type I
membrane
protein 1
Tb927.7.470 38 (+/-1) 32 * 85 (+/- 4) 182–204 Yes 4 No 297
putative type I
membrane
protein 2
Tb927.9.11480 45 (+/-4) 34 (+/-3) 87 (+/- 2) 512–537 Yes 1 No 561
putative type
IV membrane
protein
Tb927.11.7550 51 (+/-2) 38 97 (+/- 7)* 49–71, No 3 No 221
112–134,
141–163,
190–212
VAMP7B Tb927.5.3560 70 (+/-3) 62(+/-12) 81 (+/-21) Vesicle-associated
membrane protein
184–206 No No No 796
TPR-repeat
protein
Tb927.11.810 46 * 55 (+/-4) 97 (+/- 4) Tetratrico peptide
repeat [42]
No No No No 216
(Continued)
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Discussion
Maintaining cell surface composition is a vital component of cellular homeostasis. For African
trypanosomes this process is also essential to ensure integrity of the VSG monolayer, an aspect
of surface biology critical for immune evasion and additional functions encompassing nutrient
uptake and sensing. The importance of surface protein expression and trafficking in African
trypanosomes is also underscored by the recent finding that ISG75 expression level and the
endocytic apparatus are involved in suramin uptake and sensitivity. Understanding this pro-
cess is fundamental both to revealing the mode of action of suramin and for the consideration
of exploitation of this pathway for delivery of drugs into trypanosomes. Furthermore, the pro-
cess is shown here as a component of mechanisms controlling turnover of surface proteins in
trypanosomes.
Several components of the mechanisms involved in setting expression levels of VSG, ISG65,
ISG75 and the ESAG6/7 transferrin receptor are known [38] (reviewed [43]). For example,
internalisation and turnover of ISG65 and ISG75 depends on ubiquitylation and sorting by the
ESCRT system [7,10,8,27], but the identity of the ubiquitin ligases and deubiquitylating
enzymes has remained elusive. Significant divergence within the ubiquitylation system in try-
panosomes compared to animals and fungi [10] has precluded facile functional assignments
based on comparative genomics of DUB and ubiquitin ligase families. Furthermore, many pro-
teins expressed at the trypanosome surface are lineage restricted and there is little information
on expression level control or turnover [6].
The gene cohort involved in suramin sensitivity is restricted to proteins that are part of the
surface proteome and/or endosomal system. The cohort contains AP-1, a major player in pro-
tein targeting in many organisms. While roles for AP-1 in trafficking of p67, the major lyso-
somal protein of trypanosomes are known [14,22], no impact on expression or location of ISGs
was observed here. The absence of canonical dileucine adaptin-binding motifs in the cyto-
plasmic domains of ISGs is also consistent with this finding, and suggests that AP-1 mediates
an aspect of suramin-sensitivity distinct from ISG trafficking. It is possible that this is mediated
via p67 itself, which was also identified as a suramin-sensitivity determinant and is probably
directed to the lysosome via a route distinct to that for endocytosis of surface proteins. How-
ever, while evidence supports a role for AP-1 in p67 transport in insect stage cells, data based
on proteolytic processing of p67 suggests this is not the case in bloodstream-form cells [44]. A
small, but reproducible, upregulation of CatL under AP-1 knockdown was observed, suggesting
that AP-1 is involved in CatL delivery to the lysosome and possibly also its maturation, but the
Table 1. (Continued)
Annotation Protein group Protein abundance upon RNAi
(percent relative to non-induced)
Predicted features Predicted
Trans-
membrane
domain
Predicted N-
terminal
signal
Number of
lysines in
cytoplasmic
domain
Predicted
GPI-anchor
Sequence
length
(inclusive
signal seq.)TbUsp7 26h TbUsp7 48h TbVdu1 48h
ESAG5 Tb11.v5.0826 142(+/- 2) 170(+/-26) 132(+/-12) potential lipid or lipo-
polysaccha ride
binding [36,37]
No Yes NA No 464
Tb927.7.6860 480
ESAG6 Tb927.7.3250 132(+/-17) 202(+/-56) 101(+/-43)* Transferrin receptor No Yes NA Yes 397
ESAG7 Tb927.7.3260 No Yes NA No 339
ESAG2 Tb927.11.14620 114 (+/- 8) 115 (+/-21) 85(+/- 3) No Yes NA Yes 458
VSG-related
protein
Tb927.7.180 126(+/-17) 139 * 117(+/- 4)* VSG-related No Yes NA No 437
doi:10.1371/journal.ppat.1005236.t001
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Fig 8. Volcano plots of protein abundance changes. Normalised SILAC ratios, averaged from duplicates (TbUsp7) or triplicates (TbVdu1), are plotted
against the respective -log10 transformed standard deviation. Data points representing protein groups significantly shifted after 48 hours are labeled (see
also Table 1). ISG65 and ISG75 paralogs are highlighted in green and orange, respectively.
doi:10.1371/journal.ppat.1005236.g008
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mechanism remains unclear. These data do, however, demonstrate the presence of an ISG-
independent, AP-1-dependent pathway that influences suramin sensitivity, suggesting that
trafficking to the lysosome is an important factor.
By contrast, TbUsp7 and TbVdu1, two evolutionarily conserved DUBs, are critical to the
control of ISG abundance and indicate the presence of a second, ISG-dependent pathway for
suramin sensitivity. Our data suggests a model in which silencing of the respective DUB leads
to increased targeting of specific ISG proteins into the degradative arm of the endocytic path-
way (Fig 9). We propose that the most parsimonious interpretation is that TbUsp7 and
TbVdu1 impact ISG cargo uptake by directly affecting ISG stability. This is supported by sev-
eral lines of evidence; membership of the suramin-sensitivity gene cohort, demonstration of
direct, and highly specific impact on ISG expression level, homology to mammalian DUBs,
Fig 9. Model integrating suramin-sensitivity pathways, trafficking and ISG turnover. A simplified schematic of the trypanosome endomembrane system
is shown, with the flagellar pocket at top left. Teal arrows indicate ISG degradative and recycling trafficking routes, red putative AP-1-mediated transport from
the Golgi complex to the lysosome [14, 27] and gray exocytic/biosynthetic pathways. The predominant locations of ISG75, ESAG6/7 (the transferrin receptor)
and p67 (the major lysosomal protein) are indicated by icons. Evidence suggests that ISG75 is ubiquitylated at, or close to the surface (magenta) and
deubiquitylation by TbUsp7 and/or TbVdu1 is proposed to take place prior to the sorting step at the early endosome that selects for the recycling or
degradative arm of the endocytic system. TbVdu1 is known to associate with structures in this region, whilst TbUsp7 is likely cytosolic. Approximate percent
changes in the proportion of ISG75 transiting the different arms of the endocytic system are calculated from differences in half-life derived for observed ISG75
turnover changes upon TbUsp7 knockdown (Fig 5) and assuming a recycling cycle time of ~10 min. AP-1 is proposed to mediate pathways required to
deliver components to the lysosome required for suramin to translocate to the cytosol.
doi:10.1371/journal.ppat.1005236.g009
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localisation of TbVdu1 to the endosomal region, the absence of a major impact on ISG biosyn-
thesis and the ability to transfer knockdown sensitivity to the BiPN chimera. A direct demon-
stration of hyperubiquitylation has not been possible, as the expression level of the ISG75
protein itself is so greatly decreased in knockdown cells making detection of the small fraction
of ubiquitylated adduct unreliable. None-the-less, all of these data support an intimate relation-
ship between ISG turnover rates and TbUsp7 and TbVdu1.
Proteomics revealed highly specific and precise control of ISG75 and ISG65 by TbVdu1.
Silencing of TbUsp7 resulted in strong downregulation of MBAP1, a membrane protein essen-
tial for both incoming and recycling membrane traffic [33], and upregulation of several ESAG
products. Due to the presence of a high confidence predicted ubiquitylation site at the cyto-
plasmic domain of MBAP1 (Lys502, 0.96 likelihood in UbPred [45]), it is tempting to speculate
that MBAP1 steady state levels are also controlled by ubiquitylation. The observed accumula-
tion of ESAGs, including the transferrin receptor, could result from a block to endocytosis fol-
lowing MBAP1 downregulation. However, upregulated proteins form a relatively small cohort,
while the bulk surface proteome, including for example ISG64, appear unaffected by TbUsp7
knockdown, suggesting that distinct mechanisms control expression of GPI-anchored and
trans-membrane domain proteins. This also includes p67, the abundance of which was unal-
tered by the DUB knockdowns in SILAC analysis (S1 Table), suggesting very distinct mecha-
nisms for controlling surface and lysosomal protein expression. Interestingly, a VSG-related
(VR) protein, Tb927.7.180, was significantly upregulated by TbVdu1 knockdown, which pro-
vides the first evidence that these VR proteins are expressed at the surface.
TbUsp7 appears to be cytosolic [11], while TbVdu1 is, similarly to its human ortholog,
membrane associated and appears to be confined to the flagellar pocket/early endocytic com-
partments (S1 Fig). Knockdown of neither DUB led to ISG mislocalisation, except in cells with
an enlarged flagellar pocket, resulting from defective endocytosis and likely connected with
decreased MBAP1 expression. Significantly, ISG65 and ISG75 demonstrate unique aspects in
their trafficking and ubiquitylation, beyond differential sensitivity to TbUsp7 and TbVdu1,
including increased ubiquitylation of only ISG75 at the cell surface following inhibition of
endocytosis, suggesting that ISG75 is primarily ubiquitylated at the plasma membrane, while
ISG65 may be modified elsewhere. Overall, these data indicate that ISG65 and ISG75 have dis-
tinct trafficking and modification pathways, as has been suggested by other studies [46,47], and
which contribute to their differential impact on suramin sensitivity, despite being compara-
tively similar proteins. However, it is also likely that these two ISG families have distinct bind-
ing specificities, which are also relevant to accumulation of suramin. Blue-native PAGE
indicates that both proteins likely exist as complexes, with ISG65 mainly present as a dimer,
and ISG75 as dimers and higher order forms (S4 Fig); it is unclear how these biochemical dif-
ferences connect to the distinct trafficking pathways.
In common with other eukaryotes, E3 ubiquitin ligases are likely key players in ubiquityla-
tion in trypanosomes, a system that arose in Archaea prior to eukaryogenesis [48]. There are a
large number of RING and HECT family E3s encoded in the trypanosome genome, together
with representatives of the Rbx/Cullin E3 ligases. DUBs function in a temporally and spatially
distinct manner to remove ubiquitin modifications, and these two systems also modulate each
other by direct interactions. Stabilisation of cognate E3 ubiquitin ligases by deubiquitylation is
a known aspect of DUB function [49] and DUBs are themselves ubiquitylation substrates. The
mammalian ortholog of TbVdu1, is a downstream target for ubiquitylation by the Cullin-
RING E3 ubiquitin ligase component of pVHL [29], a complex that acts to control expression
of many proteins, including the transcription factor HIF-1α and also PAR3, which moderates
endocytic pathways in mammalian cells and is associated with tumorigenesis [29]. The Rbx1
component of the equivalent complex in African trypanosomes has been targeted by RNAi and
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leads to defective kinetoplast replication in insect stages, but has little impact in the blood-
stream form, while the relevant Cullin protein has no impact on replication in either life stage
(Federico Rojas, personal communication). Significantly, a likely DUB for this complex in try-
panosomes, TbVdu1 is membrane-associated and targeted to the flagellar pocket/early endo-
somes; this localisation is consistent with the elevated ISG75 ubiquitylation seen upon the
cessation of endocytosis following clathrin RNAi knockdown. These findings support the exis-
tence of a ubiquitylation switch in trypanosomes mediating ISG75 (but not ISG65) expression
levels. We have previously observed rather complex mechanisms underpinning ISG65 and
ISG75 expression, such that very limited mutations within the cytoplasmic domain, altering
three lysine codons to arginine, lead to significant differences in mRNA levels not reflected by
changes in protein level [8]. Control of ISG75 here is very similar to that of type 2 iodothyro-
nine deiodinase, which has a very short half-life but is stabilised by VDU1 in mammals [50].
In conclusion, we describe two pathways that contribute towards suramin sensitivity, an
AP-1 dependant pathway and an ISG-dependant pathway, with a particular focus on the latter.
Complex interactions between TbUsp7, ISG75 and other membrane proteins, especially
MBAP1 identifies sophisticated mechanisms coordinating surface protein expression and
intracellular targeting in trypanosomes. Both pathways are required for suramin-sensitivity,
and we speculate that the AP-1-dependent pathway is required to maintain lysosomal condi-
tions required for suramin-sensitivity, whilst the ISG75 pathway is needed for delivery of sura-
min to that compartment. The presence of a conserved Rbx/Cullin-type ubiquitylation switch,
as evidenced by TbVdu1, indicates that control of ISG75 expression is likely critical to the para-
site, although the normal physiological function of ISG75 remains to be determined. The essen-
tiality of AP1 and the presence of multiple ISG75 paralogs also may explain the remarkable
lack of emergence of suramin resistant strains in the wild. Finally, these data are further evi-
dence of the high clinical value of endocytosis in the treatment of trypanosomiasis, adding sur-
amin acquisition to a list already containing VSG recycling, antibody clearance, essentiality of
many clathrin-associated proteins and N-myristoyltransferase inhibitor sensitivity [51].
Materials and Methods
Cell culturing of T. brucei brucei
Bloodstream form (BSF) Molteno Institute Trypanosomal antigen type (MITat) 1.2, derived
from Lister strain 427 and expressing VSG221, were cultured in HMI-9 complete medium
(HMI-9 supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicil-
lin, 100 U/ml streptomycin and 2 mM L-glutamine) [52] at 37°C with 5% CO2 in a humid
atmosphere, in non-adherent culture flasks with vented caps. 2T1 cells (a variant of MITat 1.2)
were maintained in HMI-9 complete medium in the presence of phleomycin (1 μg/ml) and
puromycin (1 μg/ml). Following transfection with stem-loop RNAi plasmids, 2T1 cells were
maintained in phleomycin (1 μg/ml) and hygromycin (2.5 μg/ml) [53,54]. All TbUsp7 and
TbVdu1 RNAi experiments were performed following 48 h induction with tetracycline (1 μg/
ml). Cells harbouring the p2T7-AP-1γ RNAi construct were maintained in G418 (2.5 μg/ml)
and phleomycin (0.5 μg/ml) as described previously [14]. Cells were maintained at densities
between 105 and 2.5 x 106 cells/ml. Suramin EC50 was assessed following three days of TbVdu1
RNAi knockdown. Cells were plated at 2x103 cells/ml in 96-well plates in a two-fold dilution
series of suramin, starting from 1 μM. After three days growth, 20 μl resazurin (Sigma) at
125 μg/ml in PBS was added to each well and incubated for a further six hours at 37°C. Fluores-
cence was determined using a plate reader (Molecular Devices) with the following settings:
excitation, 530 nm; emission, 585 nm; filter cut off, 570 nm. Data were processd in Excel, and
non-linear regression analysis carried out in GraphPad Prism.
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Plasmid constructs. Gene-specific RNAi fragments of 400–600 bp were amplified with
PCR primers designed using RNAit [55] and cloned into pRPaiSL to generate stem-loop, ‘hairpin’
dsRNA to induce RNAi knockdown [54]. The following primers were used: TbUsp7SL_F (5’-
GATCGGGCCCGGTACCTTCAAGCTGTTTGGCAGTTG-3’), TbUsp7SL_R (5’-GATCTCT
AGAGGATCCAACAGGGTTCGCACGATTAC-3’), TbVdu1SL_F (5’-GATCTCTAGAGG
ATCCAACAGGATGGGACACCTCAG-3’), TbVdu1SL_R (5’-GATCGGGCCCGGTACCAC
TTTGAGCAGCGCCTACAT-3’). All constructs were verified by standard sequencing methods
(Source BioScience LifeSciences). TbVdu1 wasN-terminally tagged with GFP or six myc epitopes
at the native locus using pNATTAGX [54]. The following primers were used to amplify a 1003 bp
gene fragment: 5TbVdu1xba (5’-GATCTCTAGATTGTCATCTTCGTCGCCGGT-3’) and
3TbVdu1bam (5’-GATCGGATCCTCAGCGAAGAAAAACTCTCC-3’). Prior to introduction
into trypanosomes, pRPaiSL constructs and pNATTAGTbVdu1 were linearised with AscI orMfeI,
respectively, and purified by phenol:chloroform extraction.
Quantitative real-time polymerase chain reaction (qRT-PCR)
1 x 108 cells were harvested at 800 x g for 10 min at 4°C and washed with ice-cold PBS and
quick-frozen in dry ice for 1 min. RNA was purified using the RNeasy mini kit (Qiagen)
according to the manufacturer’s instructions. RNA concentration was quantified using an ND-
1000 spectrophotometer and Nanodrop software (Nanodrop Technologies). cDNA synthesis
and qRT-PCR reaction setup was performed as described previously [56]. qRT-PCR was per-
formed using iQ-SYBRGreen Supermix on a MiniOpticon Real-Time PCR Detection System
(Bio-Rad) and was quantified using Bio-Rad CFX Manager software (Bio-Rad). The following
primers were used for qRT-PCR: bTub-RTF (5’-CAAGATGGCTGTCACCTTCA-3’), bTub-
RTR (5’-GCCAGTGTACCAGTGCAAGA-3’); USP1 RTF (5’-GAGATGGCACCATCACT
CCT-3’), USP1 RTR (5’-GTGGGCAGCACCTCTAGAAC-3’); VDU1 RTF (5’-GTCGAAAGA
CGTGTGGGTTT-3’), VDU1 RTR (5’-GGAGCGAGGGAAGAGAGATT-3’); ISG65-RTF (5’-
GAGCATGTTGATAGAGGGATTG-3’), ISG65-RTR (5’-CATTGCTGTTCTCTGATGTC
TG-3’); ISG75-RTF (5’-GAGGGCAGCGAGGCCAAG-3’), ISG75-RTR (5’-CTTCCTACGG
CCCCTAATAAC-3’).
Transfection
3 x 107 bloodstream-form cells were harvested by centrifugation at 800 x g for 10 min at 4°C.
Cells were resuspended in 100 ul of Amaxa Human T-cell Nucleofector solution (VPA-1002)
at 4°C, mixed with 10 ug (in 5 ul) of linearised plasmid DNA and transferred to electrocuvettes.
Transfection was achieved using an Amaxa Nucleofector II with Program X-001. Cells were
then transferred to Tube A containing 30 ml of HMI-9 medium plus any appropriate antibiotic
drug for parental cell growth. Serial dilution was performed by transferring 3 ml of cell suspen-
sion from Tube A into Tube B containing 27 ml of HMI-9 medium and repeated again by
diluting 3 ml from Tube B into Tube C. 1 ml aliquots for each dilution were distributed
between three 24-well plates and incubated at 37°C. After 6 h, HMI-9 containing antibiotic
selection was added to the wells at the desired final concentration. Transformed cells were
recovered on day 5–6 post-transfection.
Immunofluorescence (IF)
Samples for IF were prepared as previously described (Leung et al., 2008). Antibodies were
used at the following dilutions: mouse and rabbit anti-HA epitope IgG (both from Santa Cruz
Biotechnology Inc.) at 1:1000, mouse 9E10 anti-myc (Sigma) at 1:1000, rabbit anti-GFP (Life
Technologies) at 1:500, rabbit anti-ISG65 and rabbit anti-ISG75 (from P. Overath, Tubingen)
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at 1:1000, rabbit anti-CatL at 1:1000 (from J. Bangs, Buffalo), mouse anti-GLP-1 at 1:1000
(from D. Russell, Cornell). Secondary antibodies were used at the following dilutions: anti-
rabbit Cy3 (Sigma) at 1:1000. Coverslips were mounted using Vectashield mounting medium
supplemented with 4’,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc.). The
cells were examined on a Nikon Eclipse E600 epifluorescence microscope fitted with optically
matched filter blocks and a Hamamatsu ORCA CCD camera. Digital Images were captured
using Metamorph software (Universal Imaging Corp.) on a Windows XP computer (Microsoft
Inc.), and the raw images were processed using Adobe Photoshop CS3 (Adobe Systems Inc.).
Protein turnover
Protein synthesis was blocked by the addition of cycloheximide (100 μg/ml) and 1 x 107 cells
were harvested at various time points by centrifugation at 800 x g for 10 min at 4°C. Cells were
washed in ice-cold PBS, then resuspended in 1 x SDS sample buffer and incubated at 95°C for
10 min. Samples were subjected to protein electrophoresis.
Western immunoblotting
Whole cell lysates and hypotonic lysis fractions were prepared as previously described (Leung
et al, 2008). Proteins were separated by electrophoresis on 12.5% SDS-polyacrylamide gels and
then transferred to polyvinylidene difluoride (PVDF) membranes (Immobilon; Millipore)
using a wet transfer tank (Hoefer Instruments). Non-specific binding was blocked with Tris-
buffered saline with 0.2% Tween-20 (TBST) supplemented with 5% freeze-dried milk and pro-
teins were detected by Western immunoblotting. The PVDF membrane was then incubated in
primary antibody diluted in TBST with 1% milk for 1 h at room temperature. Antibodies were
used at the following dilutions: monoclonal anti-HA (sc-7392, Santa Cruz) at 1:10,000, mouse
9E10 monoclonal anti-myc (Source Biosciences) at 1:5,000, rabbit polyclonal anti-GFP (Life
Technologies) at 1:5,000, rabbit polyclonal anti-ISG65 and anti-ISG75 both at 1:10,000, KMX-
1 anti-beta-tubulin at 1:2000 (Millipore), rabbit anti-CatL at 1:1000, mouse anti-GLP-1 at
1:1000. Following three washes with TBST each for 10 min, the membrane was incubated in
secondary antibody diluted in TBST with 1% milk for 1 h at room temperature. Commercial
secondary anti-rabbit peroxidase-conjugated IgG (A0545, Sigma) and anti-mouse peroxidase-
conjugated IgG (A9044, Sigma) were used both at 1:10,000. Detection was by chemilumines-
cence with luminol (Sigma) on BioMaxMR film (Kodak). Densitometry quantification was
achieved using ImageJ software (NIH). Blue Native PAGE followed byWestern blotting experi-
ments were carried out as described [57].
Radioimmunoprecipitation assay (RIPA)
1 x 107 cells were pelleted at 800 x g for 10 min at 4°C, washed twice in PBS and resuspended in
500 ul of Met/Cys-free RPMI-1640 medium supplemented with dialysed FBS followed by an
incubation at 37°C for 1 h. Cells were pulse-labeled at 37°C for 1 h with EasyTag EXPRESS
[35S] Protein Labeling Mix (PerkinElmer) at a specific activity of 200 uCi/ml (7 ul of 14.3 mCi/
ml) and then instantly cooled on ice. Cells were pelleted at 16,000 x g for 15 sec on a table top
centrifuge, washed twice with ice-cold PBS and lysed by the addition of 100 ul of RIPA buffer
[25 mM Tris-HCl pH 7.5, 150 mMNaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
and Complete Mini Protease Inhibitor Cocktail (Roche)] for 15 min on ice. Lysates were centri-
fuged for 30 s to remove nuclei and cell debris, and the supernatant transferred to a fresh tube.
13 μl of 10% SDS was added to the supernatant and incubated at 95°C for 5 min. Samples were
diluted with 750 μl of dilution buffer (50 mM Tris-HCl pH 7.5, 1.25% Triton X-100, 190 mM
NaCl, 6 mM EDTA, Complete Mini Protease Inhibitor Cocktail). 30 μl of Pansorbin
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(Calbiochem) (pre-washed and resuspended in dilution buffer) was added to the supernatant
and incubated at 4°C for 1 h. Samples were centrifuged at 16,000 x g for 5 min and the superna-
tant transferred to a fresh tube. 5 μl of anti-HA antibody was added to each sample and incu-
bated at 4°C overnight on a rotating device. Immune complexes were then isolated by the
addition of 20 μl of Protein A-Sepharose on a rotating device for 1 h at room temperature. Sub-
sequently, Sepharose beads were washed twice with wash buffer I (50 mM Tris pH 7.5, 0.1% Tri-
ton X-100, 0.02% SDS, 150 mMNaCl, 5 mM EDTA) and twice with wash buffer II (50 mM Tris
pH 7.5, 0.02% Triton X-100, 1 M NaCl). A further centrifugation step was performed for 15 s at
16,000 x g and the remaining supernatant was removed by pipetting. Samples were resuspended
in 1 x SDS sample buffer and denatured at 95°C for 5 min and subjected to 12.5% SDS-PAGE.
Gel was then immersed in destaining solution for 20 min, washed twice with distilled water and
then soaked in 1 M sodium salicylate for a further 20 min. The gel was then dried onWhatman
3MM paper for 2 h at 60°C and exposed to autoradiographic film for 1 week.
Densitometry. All fluorographs were scanned at 16-bit gray-scale resolution, and expo-
sures selected to ensure the film was not saturated. In most cases the exposures shown in the
figures represent over-exposed versions of the same data used in quantitation. Quantitation
and background subtraction was then done with ImageJ (http://rsb.info.nih.gov/ij/).
Concanavalin A (ConA) uptake assay. 1.5 x 106 cells were harvested at 800 x g for 10 min
at 4°C, washed with serum-free HMI-9 supplemented with 1% bovine serum albumin (BSA)
and incubated in serum-free HMI-9 with 1% BSA for 20 min at 4°C. Cells were then incubated
with 50 μg/ml of fluorescein isothiocyanate (FITC)-conjugated ConA (Vector Labs FL-1001)
for 20 min at 4°C. Chase was initiated by incubating cells at 37°C with samples harvested at
various time points by immediately placing on ice and washing with vPBS at 800 x g for 10 min
at 4°C. Labelled cells were fixed and co-stained as described for IF.
Stable isotype labeling by amino acids in cell culture (SILAC) labeling
HMI11 for SILAC was prepared essentially as described in [58]: IMDM depleted of L-Arginine,
L-Lysine (Thermo) and 10% dialysed (10 kDa molecular weight cutoff) fetal bovine serum
(Dundee Cell Products) was supplemented with 4 ug/ml folic acid, 110 μg/ml pyruvic acid,
39 μg/ml thymidine, 2.8 μg/ml bathocuproinedisulfonic acid, 182 μg/ml L-cysteine, 13.6 μg/ml
hypoxanthine, 200 μM β-mercaptoethanol, 0.5 μg/ml Phleomycin and 2.5 μg/ml Hygromycin.
Finally either normal L-Arginine and L-Lysine (HMI11-R0K0), or L-Arginine U−13C6 and
L-Lysine 4,4,5,5-2H4 (HMI11-R6K4) (Cambridge Isotope Laboratories) were added at 120 uM
and 240 uM respectively. RNAi was induced by addition of 1 μg/ml tetracycline. At the indi-
cated times, equal numbers of induced and uninduced cells, grown in the presence of
HMI11-R0K0 or HMI11-R6K4 respectively, were mixed, harvested by centrifugation, washed
twice with PBS containing Complete Mini Protease Inhibitor Cocktail (Roche) then resus-
pended in Laemmli buffer containing 1 mM dithiothreitol and stored at -80°C. TbUsp7 and
TbVdu1 RNAi samples were generated in duplicate and triplicate, respectively, with each repli-
cate representing a different clone. One label swap was performed in each set of replicates. The
heavy isotope incorporation at steady state was determined from one gel slice (60–80 kDa) of a
control experiment omitting induction. Samples were sonicated and aliquots containing 5 x
106 cells were separated on a NuPAGE bis-tris 4–12% gradient polyacrylamide gel (Invitrogen)
under reducing conditions. The sample lane was divided into eight slices that were excised
from the Coomassie stained gel, destained, then subjected to tryptic digest and reductive alkyl-
ation. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed by the
Proteomic Facility at the University of Dundee. The eight fractions obtained from SDS-PAGE
were subjected to LC-MS/MS on a UltiMate 3000 RSLCnano System (Thermo Scientific)
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coupled to a LTQ OrbiTrap Velos Pro (Thermo Scientific) and mass spectra analysed using
MaxQuant version 1.5 [59] searching the T. brucei brucei 927 annotated protein database
(release 8.1) from TriTrypDB [60]. Minimum peptide length was set at six amino acids, isoleu-
cine and leucine were considered indistinguishable and false discovery rates (FDR) of 0.01
were calculated at the levels of peptides, proteins and modification sites based on the number
of hits against the reversed sequence database. SILAC ratios were calculated using only peptides
that could be uniquely mapped to a given protein. If the identified peptide sequence set of one
protein contained the peptide set of another protein, these two proteins were assigned to the
same protein group.
Supporting Information
S1 Fig. TbVdu1 is membrane-associated and has a subcellular localisation consistent with
an early endocytic compartment. (A) 6mycVdu1 is found in the membrane fraction following
hypotonic lysis. S, soluble; W, wash; P, pellet. (B) Western blot shows specific expression of
GFPVdu1. Coomassie stained gels show loading. (C) GFPVdu1 localises to a region proximal to
the kinetoplast. The dashed regions are presented in the right hand panels. Cells were co-
stained with DAPI to visualise the nuclear and kinetoplast DNA. Scale bar = 2 μm. (D)
TbVdu1 knockdown has no effect on cell proliferation. Cells were grown over a period of 5
days in the presence (white squares) or absence (black squares) of TbVdu1 RNAi and cell num-
bers monitored. (E) TbVdu1 RNAi and EC50 analysis confirms the contribution of TbVdu1 to
suramin efficacy. TbVdu1 RNAi strain was grown +/-tetracycline and then subjected to EC50
analysis; non-linear regression analysis was carried out in Graphpad Prism. Representative plot
is shown; error bars represent standard error from a quadruplicate assay. Relative change in
EC50 following RNAi in three independent cell lines is shown in the box.
(PSD)
S2 Fig. ConA uptake assay in the presence and absence of TbUsp7 or TbVdu1 RNAi. Fol-
lowing induction of RNAi, cells were incubated with FITC-conjugated ConA and uptake was
monitored at 0, 10, 20, 30 and 60 min. Note that only BigEye cells are presented for TbUsp7
induced for RNAi. Induced cells that do not display the BigEye phenotype have normal ConA
uptake as in uninduced cells. All cells were co-stained with DAPI to visualise nuclear and kinet-
oplast DNA. Scale bar = 2.5 μm.
(PSD)
S3 Fig. TbUsp7 knockdown does not impact on clathrin steady state levels. TbUsp7 RNAi
was induced for 48 h and levels of clathrin were monitored by Western blotting using anti-cla-
thrin heavy chain (CLH) antibody.
(PSD)
S4 Fig. ISG65 and ISG75 are multimeric. Bloodstream-form cell lysates were subjected to
Blue Native PAGE, followed by western blotting. Molecular weight standard masses are given
in kDa on the left hand side.
(PSD)
S1 Table. Raw SILAC proteomics data. Protein groups output table of the MaxQuant analysis
of TbUsp7 RNAi (26h and 48h) and TbVdu1 RNAi (48h). False identifications (contaminants,
reverses) and peptide IDs were removed from the list. Columns G-K were added and list the
normalised ratios (induced/uninduced) for each independent experimental replicate (grey), the
respective average (orange) and standard deviation (light orange). ND; not detected.
(XLSX)
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